Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.7110
-0.0192 (-2.63%)
Oct 14, 2026, 2:45 PM EDT - Market open
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.83 million as of October 14, 2026. It is the 46,917th most valuable company in the world and the 6,298th biggest in the United States. Its market cap has increased by 24.36% in one year.
Market Cap
2.83M
Enterprise Value
-7.91M
1-Year Change
24.36%
Global Rank
Country Rank
#6,298 United States
Category
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $2.83M, a decrease of -96.87%. That is a compound annual growth rate of -44.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 2.83M | -40.23% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 3.36M |
| Eocene | 3.35M |
| HCW Biologics | 3.31M |
| Aptevo Therapeutics | 3.31M |
| 60 Degrees Pharmaceuticals | 3.22M |
| Mustang Bio | 3.12M |
| XORTX Therapeutics | 3.12M |
| Cadrenal Therapeutics | 3.11M |